Turner, Margaret

Turner, Margaret A. 2003. Strengths and Weaknesses ofthe Housing Voucher Program. Congressional Testimony prepared for the Committee on Financial Services, Subcommittee on Housing and Community Opportunity, U.S. House of Representatives, June 17, 2003. Available at www.urban.org/url.cfm lD=900635. 

All of these contributions by women chemists were invisible. No mention was made of them in an article of 1917 by the Institute of Chemistry on the work accomplished by wartime (male) chemists.19 More recently, in a lengthy review of the mobilisation of civilian chemists during the First World War,20 the only mention of a woman chemist is And so, too, left without an offer from the [Reserved Occupations] Committee, the only woman of whom we have record, Margaret Turner, of the Chemical Laboratories at Aberystwyth. 21... 

Yet Margaret K. Turner of the University College of Wales, Aberystwyth, did participate in the war effort. Turner had been hired at Aberystwyth at the beginning of the war with the rank of Demonstrator, and, in a history of the Department, it was reported that Miss Margaret Turner and, later, J. B. Whitworth took up posts as demonstrators and under the direction of the professor carried out large-scale preparations of intermediates for certain essential drugs. 22... 

Margaret Turner-Warwick was one of the first to study cyclophosphamide (CP) to treat idiopathic pulmonary fibrosis (IPF) (3). Her group report completed a double-blind randomized trial of CP for IPF, which identified several of the issues that still plague current trials in this area, including the high mortality of the disease and the apparent lack of response in patients with more severe disease at time of starting treatment (4). 

---